0000950170-23-043001.txt : 20230816
0000950170-23-043001.hdr.sgml : 20230816
20230816160124
ACCESSION NUMBER: 0000950170-23-043001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230101
FILED AS OF DATE: 20230816
DATE AS OF CHANGE: 20230816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bernard Thierry
CENTRAL INDEX KEY: 0001815490
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 231178170
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
ownership.xml
4
X0508
4
2023-01-01
0001492674
T2 Biosystems, Inc.
TTOO
0001815490
Bernard Thierry
101 HARTWELL AVENUE
LEXINGTON
MA
02421
true
false
false
false
false
Common Stock
2023-01-01
4
M
false
1550
A
4568
D
Common Stock
2023-08-06
4
M
false
454
A
5022
D
Restricted Stock Units
2023-01-01
4
M
false
1550
0
D
Common Stock
1550
0
D
Restricted Stock Units
2023-08-06
4
M
false
454
0
D
Common Stock
454
0
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
On January 1, 2022 the reporting person was granted 1,550 RSU's that vested in one installment on January 1, 2023.
On August 6, 2020 the reporting person was granted 1,363 RSU's that vest in three equal annual installments beginning on August 6, 2021.
/s/ Michael Gibbs, Attorney-in-fact
2023-08-16